To investigate possible pathways to A-419259 resistance in an unbiased manner, we generated de novo resistance to A-419259 using the Flt3-ITD+ AML cell lines MV4-11, MOLM13 and MOLM14. This evidence concerns the gene FLT3 and acute myeloid leukemia.